Skip to main content
Curis Lifesciences IPO
37.25xsubscribed

Curis Lifesciences IPO

Pharmaceuticals & Drugs
listed
₹2.40LMin. investment

Curis Lifesciences Limited IPO Details

SectorPharmaceuticals & Drugs
Price range₹120 – ₹128
IPO type
SME
Lot size1000 shares
Issue size₹27Cr
Red Herring Prospectus
Read
Market cap
₹103.48CrLower than sector avg
RevenueApr 2024 - Mar 2025
₹49.13CrLower than sector avg
Growth rate3Y CAGR
17.72%

Curis Lifesciences IPO Subscription Status

Date
QIB
NII
Retail
Total
07-Nov-25
0.0 times (X)
0.26 times (X)
0.43 times (X)
1.54 times (X)
10-Nov-25
0.0X
0.95X
1.88X
2.62X
11-Nov-25
0.0X
25.03X
21.88X
37.25X

As on 07-Nov-25, 5:30 PM

Curis Lifesciences IPO Timeline

  1. Pre-apply
    4 Nov 2025
  2. Bid start
    7 Nov 2025
  3. Bid end
    11 Nov 2025
  4. Allotment
    12 Nov 2025
  5. Release of funds
    13 Nov 2025
  6. Demat transfer
    13 Nov 2025
  7. Listing
    14 Nov 2025

About Curis Lifesciences Limited

Curis Lifesciences Limited is engaged in manufacturing pharmaceutical products such as tablets, capsules, external preparations, oral liquid, sterile ophthalmic ointments. The company’s business model involves the following main activities: loan license manufacturing, contract manufacturing and direct exports. It has served 100+ customers for loan licensing and contract manufacturing, and 2 customers for direct exports/own brand marketing, primarily in Yemen and Kenya. Product wise, major revenue contribution came from tablets, accounting for 87.90% of revenue. Loan license manufacturing contributed 0.98%, contract manufacturing for merchant exports 55.62% and domestic suppliers 43.40% as of July, 2025.

Checklist

Quality analysis
Revenue growth
Company valuation
Earnings expansion
Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Objectives of Curis Lifesciences Limited IPO

Working capital
40.87%
Curis Lifesciences will use ₹11.25 crore to fund working capital requirements.
Capital Expenditure
22.02%
₹2.44 crore for manufacturing facility upgrades and ₹3.62 crore for storage facility construction.
General corporate purposes
20.65%
Part of the IPO proceeds will be used for general corporate purposes
Product registrations
9.77%
₹2.69 crore will be used towards product registrations in other countries
Repayment of loans
6.76%
The company will use ₹1.86 crore towards repayment of outstanding secured loans.

Compare

CompanyRevenue*3Y growthPATMarket capP/E ratioD/E ratio
This IPO₹49.13Cr17.72%₹6.11Cr₹103.48Cr12.440.96
This sector (avg.)₹1,331.47Cr0%₹193.4Cr₹10,914.84Cr60.870.43
₹52,578.44Cr---₹10,980.1Cr₹3,82,765.9Cr36.980.03
₹9,360Cr---₹2,191Cr₹1,60,635Cr64.600
₹11,516.09Cr---₹1,911.25Cr₹1,34,051.5Cr62.640.42

*Revenue for financial year 2024-25. Lower P/E and D/E ratios are generally preferred.

Curis Lifesciences IPO Contact Details

Company NameCuris Lifesciences Limited

How to apply for Curis Lifesciences IPO?

  1. Step 1

    Log in to your Upstox account to access IPO investments. Next, select the current IPO section.

  2. Step 2

    Specify IPO details. Enter the number of lots and the price you wish to apply for.

  3. Step 3

    Enter UPI ID. After entering your UPI ID, click submit. This will place your bid with the exchange.

  4. Step 4

    Mandate Notification. Your UPI app will receive a mandate notification to block funds.

  5. Step 5

    Approve Request. Your funds will be blocked once you approve the mandate request on your UPI.

Curis Lifesciences Limited IPO FAQs